A detailed history of Werlinich Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 13,695 shares of ABT stock, worth $1.62 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
13,695
Previous 13,595 0.74%
Holding current value
$1.62 Million
Previous $1.42 Billion 9.75%
% of portfolio
0.91%
Previous 0.89%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$100.07 - $118.13 $10,007 - $11,813
100 Added 0.74%
13,695 $1.56 Billion
Q2 2024

Jul 15, 2024

BUY
$100.73 - $112.44 $15,109 - $16,866
150 Added 1.12%
13,595 $1.42 Billion
Q1 2024

Apr 11, 2024

SELL
$109.52 - $120.96 $547 - $604
-5 Reduced 0.04%
13,445 $1.53 Billion
Q4 2023

Jan 09, 2024

SELL
$90.19 - $110.4 $34,632 - $42,393
-384 Reduced 2.78%
13,450 $1.48 Billion
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $26,175 - $31,405
274 Added 2.02%
13,834 $1.34 Billion
Q2 2023

Nov 13, 2023

BUY
$100.78 - $112.29 $50,390 - $56,145
500 Added 3.83%
13,560 $1.48 Billion
Q1 2023

Nov 13, 2023

BUY
$96.86 - $114.01 $4,843 - $5,700
50 Added 0.38%
13,060 $1.32 Billion
Q4 2022

Nov 13, 2023

SELL
$95.06 - $111.52 $33,271 - $39,032
-350 Reduced 2.62%
13,010 $1.43 Billion
Q3 2022

Nov 13, 2023

SELL
$96.76 - $112.03 $19,352 - $22,406
-200 Reduced 1.47%
13,360 $1.29 Billion
Q1 2022

Nov 13, 2023

SELL
$114.02 - $139.04 $34,776 - $42,407
-305 Reduced 2.2%
13,560 $1.6 Billion
Q2 2021

Nov 13, 2023

BUY
$105.79 - $124.53 $10,579 - $12,453
100 Added 0.73%
13,865 $1.61 Billion
Q1 2021

Nov 13, 2023

BUY
$108.84 - $128.23 $1.5 Million - $1.77 Million
13,765 New
13,765 $1.65 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Werlinich Asset Management, LLC Portfolio

Follow Werlinich Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.